Elite Pharmaceuticals, Inc.: 10-Q filed 2017-02-09

Name: Elite Pharmaceuticals, Inc.: 10-Q filed 2017-02-09
Creator: Elite Pharmaceuticals, Inc.

What Elite Pharmaceuticals, Inc. reported in its quarterly report filed 2017-02-09 (fiscal Q3 2017): 40 published measures, 116 facts as tagged in accession 0001144204-17-007071.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-02-09
Fiscal period: fiscal Q3 2017
Accession: 0001144204-17-007071 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	36,199,669	USD
At 2016-03-31	31,674,149	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-12-31	10,153,140	USD
At 2016-03-31	20,510,671	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-12-31	26,046,529	USD
At 2016-03-31	-33,122,237	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-12-31	13,283,362	USD
At 2016-03-31	11,512,179	USD
At 2015-12-31	8,103,280	USD
At 2015-03-31	7,464,180	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,666,750	USD	92
2016-04-01 to 2016-12-31	7,001,375	USD	275
2015-10-01 to 2015-12-31	-12,232,964	USD	92
2015-04-01 to 2015-12-31	-9,182,021	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-12-31	-135,663,372	USD
At 2016-03-31	-142,664,747	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	904,763,117	shares	92
2016-04-01 to 2016-12-31	811,794,206	shares	275
2015-10-01 to 2015-12-31	684,773,829	shares	92
2015-04-01 to 2015-12-31	665,720,299	shares	275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	910,505,291	shares	92
2016-04-01 to 2016-12-31	817,536,320	shares	275
2015-10-01 to 2015-12-31	684,773,829	shares	92
2015-04-01 to 2015-12-31	665,720,299	shares	275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	0	USD/shares	92
2016-04-01 to 2016-12-31	0.03	USD/shares	275
2015-10-01 to 2015-12-31	-0.05	USD/shares	92
2015-04-01 to 2015-12-31	-0.05	USD/shares	275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	0	USD/shares	92
2016-04-01 to 2016-12-31	0	USD/shares	275
2015-10-01 to 2015-12-31	-0.05	USD/shares	92
2015-04-01 to 2015-12-31	-0.05	USD/shares	275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-1,870,114	USD	92
2016-04-01 to 2016-12-31	-1,870,114	USD	275
2015-10-01 to 2015-12-31	0	USD	92
2015-04-01 to 2015-12-31	0	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-12-31	8,719,385	USD
At 2016-03-31	8,110,721	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-1,722,423	USD	92
2016-04-01 to 2016-12-31	-4,164,583	USD	275
2015-10-01 to 2015-12-31	-2,712,799	USD	92
2015-04-01 to 2015-12-31	-8,886,646	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	20,621,388	USD
At 2016-03-31	16,713,956	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	55,563	USD	92
2016-04-01 to 2016-12-31	181,883	USD	275
2015-10-01 to 2015-12-31	68,119	USD	92
2015-04-01 to 2015-12-31	207,376	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-12-31	4,681,266	USD
At 2016-03-31	4,640,189	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-12-31	1,355,371	USD
At 2016-03-31	1,804,429	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-12-31	544,677	USD
At 2016-03-31	1,530,296	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	2,326,321	USD	92
2016-04-01 to 2016-12-31	6,696,079	USD	275
2015-10-01 to 2015-12-31	4,071,000	USD	92
2015-04-01 to 2015-12-31	12,742,962	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-12-31	6,028,814	USD
At 2016-03-31	3,293,729	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	603,898	USD	92
2016-04-01 to 2016-12-31	2,531,496	USD	275
2015-10-01 to 2015-12-31	1,358,201	USD	92
2015-04-01 to 2015-12-31	3,856,316	USD	275

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,726,751	USD	92
2016-04-01 to 2016-12-31	5,755,997	USD	275
2015-10-01 to 2015-12-31	835,675	USD	92
2015-04-01 to 2015-12-31	3,447,172	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,526,183	USD	92
2016-04-01 to 2016-12-31	4,312,337	USD	275
2015-10-01 to 2015-12-31	3,174,311	USD	92
2015-04-01 to 2015-12-31	10,012,623	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-12-31	911,145,171	shares
At 2016-03-31	711,444,352	shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-12-31	15,950,718	USD
At 2016-03-31	14,837,122	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-12-31	7,231,333	USD
At 2016-03-31	6,726,401	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2016-12-31	6,419,091	USD
At 2016-03-31	6,411,799	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-12-31	439,805	USD
At 2016-03-31	437,673	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-12-31	29,175	USD
At 2016-03-31	47,422	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-12-31	1,802,475	USD
At 2016-03-31	555,352	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-12-31	764,535	USD
At 2016-03-31	377,752	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-203,364	USD	92
2016-04-01 to 2016-12-31	5,131,261	USD	275
2015-10-01 to 2015-12-31	-12,232,964	USD	92
2015-04-01 to 2015-12-31	-9,182,021	USD	275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,666,750	USD	92
2016-04-01 to 2016-12-31	27,715,661	USD	275
2015-10-01 to 2015-12-31	-37,018,704	USD	92
2015-04-01 to 2015-12-31	-32,610,594	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	694,321	USD	92
2016-04-01 to 2016-12-31	2,060,380	USD	275
2015-10-01 to 2015-12-31	654,839	USD	92
2015-04-01 to 2015-12-31	1,991,219	USD	275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	166,602	USD	92
2016-04-01 to 2016-12-31	504,932	USD	275
2015-10-01 to 2015-12-31	173,914	USD	92
2015-04-01 to 2015-12-31	492,625	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	504,932	USD	275
2015-04-01 to 2015-12-31	492,625	USD	275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,519,059	USD	92
2016-04-01 to 2016-12-31	9,295,844	USD	275
2015-10-01 to 2015-12-31	-9,520,165	USD	92
2015-04-01 to 2015-12-31	-295,375	USD	275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	5,770,163	USD	275
2015-04-01 to 2015-12-31	3,289,198	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	-985,619	USD	275
2015-04-01 to 2015-12-31	-816,579	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	2,735,085	USD	275
2015-04-01 to 2015-12-31	149,611	USD	275

Inspect the source

Entity: Elite Pharmaceuticals, Inc. / CIK 0001053369
Captured: 2026-09-20T05:17:33.154Z
SEC response SHA-256: b91e0331a01f96870ee44e841f605bd504e1bc784022b77f374cfe93dc363314

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001053369.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))